High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer

INTRODUCTION: OX-40 co-stimulatory signaling plays a role in mounting anti-tumor immune responses and clinical trials targeting this pathway are ongoing. However, the association of with OX-40 protein expression with clinical outcomes and pathological features in non-small cell lung cancer (NSCLC) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Massarelli, Erminia, Lam, Vincent K., Parra, Edwin R., Rodriguez-Canales, Jaime, Behrens, Carmen, Diao, Lixia, Wang, Jing, Blando, Jorge, Byers, Lauren A., Yanamandra, Niranjan, Brett, Sara, Morley, Peter, Sharma, Padmanee, Allison, James, Wistuba, Ignacio I., Heymach, John V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915970/
https://www.ncbi.nlm.nih.gov/pubmed/31843013
http://dx.doi.org/10.1186/s40425-019-0827-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915970/
https://www.ncbi.nlm.nih.gov/pubmed/31843013
http://dx.doi.org/10.1186/s40425-019-0827-2

Ejemplares similares